Analyst Recommendations

Jefferies analyst issues BUY recommendation for GSK on June 4, 2024 08:35AM ET. The previous analyst recommendation was Buy.GSK was trading at $40.88 at issue of the analyst...

June 4, 2024   GSK 1.23%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for SR on June 4, 2024 08:04AM ET. The previous analyst recommendation was Equal-Weight.SR was trading at $61.31 at issue of the...

June 4, 2024   SR -1.17%

B. Riley analyst issues BUY recommendation for CCIF on June 4, 2024 08:15AM ET. CCIF was trading at $8.37 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10...

June 4, 2024   CCIF -5.81%

Rodman & Renshaw analyst issues BUY recommendation for ANVS on June 4, 2024 08:26AM ET. ANVS was trading at $6.81 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest...

June 4, 2024   ANVS 29.76%

Lake Street analyst issues BUY recommendation for LUNG on June 4, 2024 08:09AM ET. LUNG was trading at $6.9 at issue of the analyst recommendation.The overall analyst consensus...

June 4, 2024   LUNG -4.36%

Janney Montgomery analyst issues NEUTRAL recommendation for NWN on June 4, 2024 08:04AM ET. NWN was trading at $37.58 at issue of the analyst recommendation.The overall analyst consensus...

June 4, 2024   NWN -0.46%

Wells Fargo analyst issues UNDERWEIGHT recommendation for ENB on June 4, 2024 06:34AM ET. The previous analyst recommendation was Underweight.ENB was trading at $36.43 at issue of the...

June 4, 2024   ENB 0.20%

H.C. Wainwright analyst issues BUY recommendation for CRBU on June 4, 2024 06:46AM ET. The previous analyst recommendation was Buy.CRBU was trading at $2.145 at issue of the...

June 4, 2024   CRBU -5.03%

Oppenheimer analyst issues OUTPERFORM recommendation for LVRO on June 4, 2024 06:41AM ET. The previous analyst recommendation was Outperform.LVRO was trading at $6.47 at issue of the analyst...

June 4, 2024   LVRO 5.24%

Benchmark analyst issues BUY recommendation for SPOT on June 4, 2024 06:48AM ET. The previous analyst recommendation was Buy.SPOT was trading at $313.62 at issue of the analyst...

June 4, 2024   SPOT 1.19%